Digital Prescribing Integrity: Preventing Misuse in Asynchronous Telehealth

By Kevin Devasia, Deputy VP, Rajagiri Telemedicine Services

Asynchronous telehealth allows patients to receive healthcare through online questionnaires, uploaded images, and medical records without a live consultation. While this approach improves access and convenience, it also creates challenges in ensuring safe and responsible prescribing.

Without real-time interaction or physical examination, healthcare providers may find it difficult to verify patient identity, assess medical conditions, identify drug misuse, or detect inaccurate information. Strong safeguards are therefore essential to protect patients and maintain prescribing integrity.

Key Risks in Asynchronous Prescribing

Several factors can increase the risk of inappropriate prescribing:

• Identity fraud: Patients may provide false identities or inaccurate personal information.
• Misleading information: Patients may alter questionnaire responses to qualify for specific medications.
• Incomplete medical history: Missing information about existing conditions, allergies, or current medications can compromise patient safety.
• Medication misuse: Weak screening may increase the risk of drug diversion or inappropriate repeat prescriptions.
• Conflicts of interest: Platforms that benefit financially from prescription volume may face pressure to prioritize sales over clinical judgment.

These risks highlight the limitations of relying solely on self-reported information and automated questionnaires.

Regulatory & Legal Considerations

Digital prescribing platforms must comply with applicable federal and state laws, medical licensing requirements, and professional standards.

In the United States, the Ryan Haight Act and related regulations establish requirements for prescribing controlled substances via the internet. The applicable rules depend on the medication, the clinical circumstances, and any relevant exceptions.

State medical boards also require appropriate patient evaluation and a valid practitioner-patient relationship. In addition, healthcare platforms must structure their financial arrangements to avoid unlawful inducements and protect independent clinical decision-making.

Compliance requires regular legal review because telehealth regulations vary by jurisdiction and continue to evolve. Digital prescribing platforms must comply with applicable federal and state laws, medical licensing requirements, and professional standards.

In the United States, the Ryan Haight Act and related regulations establish requirements for prescribing controlled substances via the internet. The applicable rules depend on the medication, the clinical circumstances, and any relevant exceptions.

State medical boards also require appropriate patient evaluation and a valid practitioner-patient relationship. In addition, healthcare platforms must structure their financial arrangements to avoid unlawful inducements and protect independent clinical decision-making.

Compliance requires regular legal review because telehealth regulations vary by jurisdiction and continue to evolve.

Strategies to Improve Prescribing Integrity

Healthcare platforms can reduce prescribing risks through four key measures:

1. Reliable identity verification: Use government-issued identification and appropriate verification technologies to confirm patient identity and reduce impersonation.
2. Access to medical history: Where legally permitted, integrate prescription drug monitoring programs (PDMPs), health information exchanges (HIEs), and electronic health records to identify relevant medications, conditions, and potential safety concerns.
3. Stronger intake screening: Use adaptive questionnaires, consistency checks, and clinical escalation procedures to identify incomplete or contradictory responses. Patients who are denied treatment should receive appropriate guidance rather than simply being allowed to repeatedly modify answers to obtain approval.
4. Independent clinical oversight: Compensate providers in ways that protect clinical independence, conduct regular peer reviews, and maintain auditable records of prescribing decisions. Clinicians should have sufficient time and information to assess each case properly.

Building a Safer Digital Prescribing System

A trustworthy platform should separate clinical decision-making from medication sales and fulfillment. Prescriptions should be based on documented medical need, an adequate clinical assessment, and consideration of contraindications and patient-specific risks.

Secure audit trails, privacy protections, clear follow-up pathways, and periodic system reviews can further strengthen accountability. Automated tools should support-not replace- professional clinical judgment.

Conclusion

Asynchronous telehealth can make healthcare more accessible, but convenience must not come at the expense of patient safety. Reliable identity verification, access to relevant medical records, robust intake screening, and independent provider oversight are essential to preventing prescribing misuse.

By combining appropriate technology with strong clinical governance and regulatory compliance, digital health platforms can deliver convenient care while maintaining the integrity and safety of prescribing.

Disclaimer: This is an authored article; DHN is not liable for the claims made in the same.

Stay tuned for more such updates on Digital Health News